The Vial Dermatology CRO is thrilled to welcome Jonathan Zung, PhD, as the newest addition to the Vial Scientific Advisory...
© 2022 Vial. All rights reserved
Press Releases
Vial to Launch Oncology CRO, Arati Rao, M.D. named as First Advisor
San Francisco, CA. June 1, 2022 — Vial has announced that they will be expanding their CRO into Oncology. This...
Vial to host an advisory board with Dr. Raj Maturi and leading Ophthalmology researchers at 2022 ARVO Conference
San Francisco, CA. May 1, 2022 — In conjunction with ARVO 2022, Vial announced that they will be hosting an...
Vial announces it will be launching a Next-Gen Ophthalmology CRO ahead of ARVO 2022
San Francisco, CA. April 28, 2022 — After the successful launch of their Dermatology CRO, the fast-growing San Francisco healthcare...
Vial launches Ophthalmology Site Network with Dr. Raj Maturi as the first PI in the network
San Francisco, CA. March 24, 2022 — Vial has officially expanded into Ophthalmology with the launch of the Vial Ophthalmology...
Arshad M. Khanani M.D., M.A. Joins Vial as an Advisor
San Francisco, CA. March 21, 2022 — The Vial Ophthalmology network welcomes Arshad M. Khanani, MD, MA as an Advisor....
Dr. David Pariser joins Vial’s Scientific Advisory Board
San Francisco, CA. March 10, 2022 — The Vial Dermatology CRO announced the addition of Dr. David Pariser, MD to...
Vial announces Dr. Mark Lebwohl to Scientific Advisory Board
San Francisco, CA. February 20, 2022 — The Vial Dermatology CRO announced the addition of Mark Lebwohl, MD, MPH to...
Vial announces advisory board with Dr. Leon Kircik and leading Dermatology research sites at 2022 Maui Dermatology Conference
San Francisco, CA. January 24, 2022 — Vial announces that in conjunction with the 2022 Maui Dermatology Conference it will host...
